Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Clovis Oncology
Biotech
Novartis pays out $40M cash in another radiopharmaceutical deal
Novartis is offering up to $425M in biobucks for exclusive licensing rights to 3B Pharmaceuticals’ FAP-targeting peptide tech.
Gabrielle Masson
Apr 24, 2023 1:53pm
Clovis needs cash now to stem looming financial challenges
Aug 8, 2022 1:44pm
Clovis strikes 3B deal to move into radiopharmaceuticals
Sep 23, 2019 8:35am
Clovis pays to settle SEC claims about ‘ill-gotten gains’
Sep 19, 2018 9:59am
Clovis loses Servier pact, agrees to settle SEC case
Aug 2, 2018 9:40am
Cancer upstart Gritstone gains major $93M series B
Sep 7, 2017 6:30am
